Skip to content

Effect of Ciprofol Injection on Postoperative Cognitive Function

A Controlled Study on the Impact of Ciprofol Injection on Postoperative Cognitive Function and Its Mechanism

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07673978
Enrollment
298
Registered
2026-06-29
Start date
2026-06-01
Completion date
2026-12-30
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Cognitive Dysfunction

Brief summary

This study aims to explore the effect of ciprofol on the postoperative cognitive function of inpatients undergoing gastrointestinal endoscopy examination, to compare the anesthetic effects and differences in adverse reactions of propofol and ciprofol in gastrointestinal endoscopy , to compare the incidence of postoperative cognitive decline in patients undergoing gastrointestinal endoscopy examination between propofol and coprofol, and to optimize the anesthesia medication regimen for patients undergoing gastrointestinal endoscopy examination.

Interventions

patients in the Ciprofol group will use ciprofol to complete the painless gastroscopy and colonoscopy treatment.

DRUGPropofol group

patients in the propofol group will use propofol to complete the painless gastroscopy and colonoscopy treatment.

Sponsors

The Second Affiliated Hospital of Chongqing Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age: 18-65 years old, ASA grade I-Ⅲ, BMI index: 18.5-30 kg/m ² 2. Patients who plan to undergo gastroscopy or colonoscopy in our hospital 3. The preoperative assessment of the MOCA scale in patients scheduled for elective surgery indicated normal cognitive function 4. dextromanuality 5. Voluntarily participate in this study and sign the informed consent form

Exclusion criteria

1. Pregnant or lactating women 2. Patients who have had cardiovascular and cerebrovascular accidents in the past 3. Patients with severe diseases of the cardiovascular system, respiratory system and liver and kidney system 4. Patients with obstructive sleep apnea syndrome 5. Patients with concurrent neurological or mental system diseases, or those with incomplete intellectual development 6. Patients allergic to ciprofol or propofol drugs 7. Patients with braking, visual/auditory impairments 8. Patients with psychotropic drug addiction or alcohol dependence 9. Patients who themselves or their attending physicians refused to participate in the study

Design outcomes

Primary

MeasureTime frame
The difference in the incidence of cognitive function decline between ciprofol and propofol in patients undergoing painless gastroscopy and colonoscopy treatmentFrom the time the patient was enrolled in the study to 24 hours after the treatment

Secondary

MeasureTime frameDescription
Intraoperative and postoperative adverse eventsFrom the time the patient enters the operating room to 24 hours after the treatment
Blood Pressure (mmHg)From entering the operating room to leaving it (before anesthesia, after induction, and 5 minutes、10 minutes 、20 minutes 、30 minutes 、40 minutes、50 minutes、60 minutes after the operation began)Non-invasive BP measured by cuff after entry and intermittently during surgery. Hypotension: SBP decrease \>30% from baseline; Hypertension: SBP increase \>30% from baseline.
Heart Rate (beats/min)From entering the operating room to leaving it (before anesthesia, after induction, and 5 minutes、10 minutes 、20 minutes 、30 minutes 、40 minutes、50 minutes、60 minutes after the operation began)Read from monitor. Bradycardia: \<50 bpm or decrease ≥25% from baseline; Tachycardia: \>100 bpm or increase ≥25% from baseline.
Respiratory Rate (breaths/min)From entering the operating room to leaving it (before anesthesia, after induction, and 5 minutes、10 minutes 、20 minutes 、30 minutes 、40 minutes、50 minutes、60 minutes after the operation began)Read from monitor or counted over 1 min. Respiratory depression: \<8 breaths/min lasting \>30 sec.
Oxygen Saturation (Pulse Oximetry)From entering the operating room to leaving it (before anesthesia, after induction, and 5 minutes、10 minutes 、20 minutes 、30 minutes 、40 minutes、50 minutes、60 minutes after the operation began)Read from monitor. Hypoxemia: SpO2 \<90% lasting \>15 sec.

Countries

China

Contacts

STUDY_DIRECTORGuangyou Duan

The Second Affiliated Hospital of Chongqing Medical University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 30, 2026